Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Tirzepatide
Health
CagriSema
Obesity
Disability
Diet and Fitness
Cancer
Heart Disease
Antibiotic Resistance
Reproductive Health
Mental Health
Mounjaro
Topics

Advertisement

Advertisement

Tirzepatide

Share

Top Latest Popular

Earlier Today

Association between tirzepatide use and risk of suicidal ideation among individuals with obesity and major depressive disorder Nature.com 05:47

Yesterday

Up to 70 Lbs Down: Did Retatrutide Just Beat Ozempic and Mounjaro? Dibesity 03:32 Sat, 24 Oct

Friday

Menopause bone loss: Droitwich surgeon urges women to take action Worcester News 05:12 Fri, 23 Oct

Advertisement

Advertisement

Hanmi's 1st Korean-developed GLP-1 obesity drug set for Oct. 29 launch: Yonhap Korea Biomedical Review 01:27 Fri, 23 Oct

MPs demand weight management overhaul amid ‘unambitious’ Mounjaro rollout Read Now Pulse 00:10 Fri, 23 Oct

Thursday

Twenty AGs Issue Letter on Chinese-Sourced Ingredients in Some Compounded GLP-1s and Peptides JD Supra 16:25 Thu, 22 Oct

Can a GLP-1 Change Your Sex Life? Men's Health 14:32 Thu, 22 Oct

GLP-1 weight-loss drugs change how people eat, but nausea needs closer study The Conversation (UK) 13:41 Thu, 22 Oct

Yes, GLP-1 Hair Loss Is Real. But It Doesn’t Last Long—and You Can Minimize the Damage. Men's Health 13:11 Thu, 22 Oct

Pharmacist shares 'rare condition' affecting some people taking Mounjaro or Wegovy Irish Mirror 08:42 Thu, 22 Oct

GLP-1 drugs could transform public health like antibiotics, obesity expert says Korea Biomedical Review 05:31 Thu, 22 Oct

Pharmacist 'rare condition' alert for anyone taking Mounjaro Wegovy or Ozempic Dublin Live 05:06 Thu, 22 Oct

Wednesday

Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives Boston Globe 23:29 Wed, 21 Oct

GLP-1 drug distributed nationwide under recall The Independent 21:41 Wed, 21 Oct

Tirzepatide Response in Man With Mitochondrial Myopathy Raises GLP-1 Muscle Concerns Rare Disease Advisor 19:47 Wed, 21 Oct

FDA recalls GLP-1 drug, other injectable medication over sterility concerns FOX13 Seattle 19:19 Wed, 21 Oct

Another Incretin Drug Proves Mettle in Sleep Apnea Medpage Today 16:53 Wed, 21 Oct

Advertisement

Alert: Nationwide Recall of GLP-1 Meds Good Housekeeping (US) 16:09 Wed, 21 Oct

2 Pharmacies Recall GLP-1 Weight Loss Injectables NTD News 16:05 Wed, 21 Oct

When To Consider Medication for Weight Loss NewsMax 15:30 Wed, 21 Oct

Hospital admissions for complex CVRM conditions represent a ‘failure of our systems’, says NHS England clinical director The Diabetes Times 15:02 Wed, 21 Oct

Novo's CagriSema Delivered 25% Weight Loss in Women. Could It Help Turn Around the Beaten-Down Stock? The Motley Fool 13:06 Wed, 21 Oct

Women Lost 25% of Body Weight on CagriSema in Trial Analysis, but Most Users Had Digestive Side Effects Medical Daily 12:48 Wed, 21 Oct

Menopause Therapy Might Boost GLP-1 Weight Loss NewsMax 12:48 Wed, 21 Oct

CagriSema helps women lose 25% of their weight in study pharmaphorum 12:45 Wed, 21 Oct

Virta Health Reports 37% Greater Weight Loss When GLP-1s are Paired with its AI-enabled Personalized Nutrition Business Wire (Press Release) 11:17 Wed, 21 Oct

HSE could be saving nearly €150m annually by using more biosimilar drugs The Irish Times 06:03 Wed, 21 Oct

Over 70,000 GLP-1 obesity drug prescriptions issued despite duplicate-use warnings Korea Biomedical Review 06:01 Wed, 21 Oct

Some GLP-1 injections recalled due to 'lack of assurance of sterility' Los Angeles Times 02:04 Wed, 21 Oct

Tuesday

Tirzepatide Correlates With Improved Liver Outcomes in Patients With PBC Rare Disease Advisor 21:01 Tue, 20 Oct

Started a GLP-1 drug like Ozempic or Mounjaro? Here’s what you need to know about nutrition The Conversation (UK) 20:25 Tue, 20 Oct

Compound GLP-1 injections are being recalled. Here’s why Cardinal & Pine 18:05 Tue, 20 Oct

Compounded tirzepatide recalled after FDA warning pharmaphorum 17:17 Tue, 20 Oct

Ixekizumab Plus Tirzepatide Yields Dual Benefits in Psoriatic Disease Dermatology Advisor 15:51 Tue, 20 Oct

GenesisL1 Opens Its Scientific Blockchain to AI Agents with GL1X, an Open-Source Explorer and On-Chain Bioinformatics Laboratory PR Newswire (Press Release) 14:22 Tue, 20 Oct

GLP-1 Users with Sleep Apnea Had About 40% Lower Acute Respiratory Failure Risk in Early CHEST Data Medical Daily 07:36 Tue, 20 Oct

Monday

Black mold, bugs found at Chinese plants making GLP-1 compounding agents Los Angeles Times 21:26 Mon, 19 Oct

Anti-Obesity Medications Show Promise in the Management of Pulmonary and Sleep Disorders Pulmonology Advisor 19:35 Mon, 19 Oct

Helix to Present Three-Year Genomic Screening Outcomes at Ashg 2026 Opening Plenary PR Newswire (Press Release) 18:18 Mon, 19 Oct

Lilly’s Omvoh leads to 50% clinical remission rate in paediatric UC Clinical Trials Arena 17:26 Mon, 19 Oct

Advertisement

My Local News

Advertisement

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS